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Abstract 
 
Background: The current study aimed to evaluate the role of carnitine in combination with vitamin E in protection 
against myocardial infarction induced by isoproterenol (ISO) in rats.  
Materials and Methods: Rats were grouped into 5 (each 10 rats): Group I. Control fed a standard diet. Group III: Rats 
were injected with vitamin E (100 IU/kg bw, i.p) daily. Group IV: Rats were given carnitine (20 mg/kg bw, i.p) daily 
.Group V: Rats were injected with   both vitamin E (100 IU/kg bw, i.p) and carnitine (20 mg/kg bw, i.p) daily. On 7
th
, 
8
th
, and 9
th
 day, rats   in groups (II-V) were injection i.p with ISO (55mg/kg b.w for successive three days). The 
treatment with carnitine and vitamin E were continuous for 21 days.  
Results: Canirine combined with vitamin E significantly increased coronary flow (CF) (P<0.001) in rats injected with 
ISO. The recovery of rate pressure product (RPP) and left ventricular developed pressure (LVDP) were significantly 
improved in treated rats in comparison to untreated. The rats administrated with ISO resulted in a significant elevation 
of serum enzymes (CK-MB and LDH) compared with control group (p<0.001). However, it returned to about normal. 
ISO administration resulted in a significant elevation in the levels of malondialdehyde (MDA) and nitric oxide (NO) as 
compared with control (p<0.001) and a significant reduction in the activities of GSPxase and GSRase (p<0.001) 
compared with control group. The levels of cardiac inflammatory markers interleukine-6 (IL-6) and tumor necrosis 
factor (TNF- α) were markedly elevated in rats injected with ISO compared with control group. Vitamin E combined 
with carnitine reversed these effects. However, pretreatment with vitamin E or carnitine or combined together showed a 
significant reduction in MDA and NO (p<0.001) and a significant elevation in the activities of GSPxase and GSRase 
(p<0.001) as compared to ISO injected group. The combined effect was more significant than individual ones.  
Conclusion: Vitamin E combined with carnitine exerts potential protective effect against MI through suppression of 
inflammatory mediators and enhancement of antioxidant activity.   
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Introduction 
 
Myocardial infarction (MI) is one of the most cardiovascular disorders that caused by sudden blockage of 
blood supply to myocyte and should be reperfused within hour to complete recovery [Kendler,1983]. The etiology of 
MI including hypertension, diabetes mellitus, lifestyle, environmental pollution and stress [De Viovo and Tein,1990]. 
Experimentally, MI can be induced by injection of animals with isoproterenol (ISO) that act as sympathomimetic 
agonist [Rebouche and Chenard,1991].  
Isoproterenol (ISO) is a synthetic catecholamine was known to have a toxic effect on the heart. The 
mechanisms that ISO -induced cardiac damage through generation of reactive oxygen species and depletion of 
antioxidant capacity. The therapeutic strategy for treatment of MI have many side effects. Replacement therapy by 
natural products play an important role in the management of many diseases, including cardiovascular diseases.  
L-Carnitine is an important fatty acyl carrier from cytosol to mitochondrial matrix for oxidation of long chain fatty 
acids [Cave etal.,2008].  It obtained from diet or can be synthesized from lysine and methionine [Rebouche, 1992]. 
Vitamin C, iron, vitamin B6 and niacin are required as coenzymes. Deficiency of carnitine resulted decreased energy 
supplied by heart, nervous system and skeletal muscles [Lombard etal.,1989].  Vitamin E (γ-tocopherol) one of fat 
soluble vitamin possesses important biological functions as cell proliferation [9], improvement of endothelial cell [Vaz 
etal.,2002].  
Many trails have been done to explore the rational of carnitine and vitamin E in protection against different 
diseases. It was found that, methotrexate given in rats showed body weight reduction, elevation in MDA levels, and 
Huwait et al., Afr J Tradit Complement Altern Med. (2017) 14(2):25-32 
doi:10.21010/ajtcam.v14i2.4 
26 
 
reduction of SOD activity. However, vitamin E and L-carnitine treatments suppressed lipid peroxidation and enhance 
SOD activity [Rebouche, 2006]. 
In addition, skeletal anomalies incidence including limbs, vertebrae, and sternum defects were decreased by L-
carnitine. The mean of weight and length of animals' fetuses received L-carnitine were significantly greater than those 
received only Cyclophosphamide. In conclusion, L-carnitine significantly decreased teratogenicity induced by 
Cyclophosphamide.  
For this reason, the rational of the present study is to assessing the useful of carnitine in combination with 
vitamin E in protection against MI induced by ISO in rats. We hope to deduce a new regime for protection against 
CHD. 
 
Materials and Methods 
Materials 
 
Isoproterenol (ISO): Isoproterenol hydrochloride was purchased from Sigma Chemical Co., USA. Vitamin E 
and carnitine were obtained from GNC Store at Jeddah, Saudi Arabia. 
 
Animals 
 
This study was carried out on a total of 50 adult male rats weighing 150–200 g. The animals were housed in 
steel cages and left for one week- before start the experiment. The handling of animals according to ethical committee 
of the university. 
 
Design of the experiment 
 
Rats were grouped   into 5 groups (each 10 rats): Group I. Control fed a standard diet. Rats in groups (II-V) 
were i.p injection with ISO (55mg/kg b.w for successive three days) for induction of myocardial infarction. Group: 
Kept untreated.  Group III: Rats were injected with vitamin E (100 IU/kg bw, i.p) daily. Group IV: Rats were given 
carnitine (20 mg/kg bw, i.p) daily .Group V: Rats were injected with vitamin E (100 IU/kg bw, i.p) and carnitine (20 
mg/kg bw, i.p) daily. On 7
th
, 8
th
, and 9
th
 day of the treatment with carnitine and vitamin E were continuous for 21 days.  
 
Assessment of Cardiac function and coronary flow 
 
Blood sample was collected after anesthesia with thiopental. Sera were separated by centrifugation at 4000 g 
at 4°C for 15 minutes and stored at -80°C. Heart was removed, rinsed from blood in buffer saline pH 7 and stored at -
80°C. Heart from different groups treated with either Vitamin E or carnitine or both were excised and transferred to in 
ice-cold Krebs solution. The heart was cannulated and retrograde perfused through the aorta in Krebs solution (mmol/l: 
NaCl 118, NaHCO3 25, KCl 4.8, KH2PO4 1.2, MgSO4 1.2, Glucose 11 and CaCl2 1.2) at pH 7.4. Following removal 
of the left atrial appendage, a deflated water filled latex balloon was inserted through the mitral valve in to the left 
ventricle. Continuous monitoring of cardiac performance. The index of myocardial function includes heart rate (HR; 
cardiac spontaneous rhythm was counted per min), and the rate pressure product (RPP=LVDP×HR). (LVDP) left 
ventricular developed pressure. Coronary flow (CF) was measured by timed collections of the coronary effluent. 
 
Biochemical Assays 
 
Serum   aspartate transaminase (AST), lactate dehydrogenase (LDH), and creatine kinase (CKMB) were 
estimated by colorimetric method using commercial KIT from Biomedical [Thygesen etal., 2010].  
 
Assay of inflammatory cytokines levels of IL-6, TNF-𝛼, malondialdehyde (MDA) and antioxidant enzymes in 
cardiac tissue. 
 
One gram cardiac tissue was homogenized in 9 volumes of ice-cold saline and centrifuged at 8000 g at 4°C for 
20 min. The amount of protein in supernatant was measured according to [16] using bovine serum albumin as standard. 
Malondialdehyde (MDA) was measured according to [Maron,1979]. Nitric oxide was determined as nitrate according 
to [Afrah etal.,2013]. SOD activity was determined by the nitro blue tetrazolium reduction method [Habig etal.,1974]. 
glutathione peroxidase [Pagila and Valentine, 1969], glutathione reductase [Deore etal.,2011]. Levels of cytokines were 
measured by ELISA kits from BIORAD (England). 
 
Histopathological examination 
 
Heart tissue was fixed in buffer formalin and embedded in paraffin, then serial sections (10 𝜇m thick) were cut 
using microtome. Each section was stained with hematoxylin and eosin (H&E). The sections were examined under the 
light microscope. The degree of necrosis was graded according to inflammation and necrosis:  
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[−] absence of inflammation edema. 
[+] spotted area of inflammation edema.  
[++] many area of inflammation, edema and necrosis.  
[+++] massive area of inflammation, edema and necrosis. 
 
Statistical Analysis 
 
Data obtained were analyzed using the program SPSS 15.0 for Windows. Data were presented as mean ± SD. 
For comparison between multiple groups, data were analyzed by ANOVA. Differences were considered to be 
statistically significant when P<0.05. 
 
Results  
Cardiac function and coronary flow 
 
The heart efficacy function parameters showed that, the mean of CF in ISO rats treated with combined 
carnitine and vitamin E significantly increased in compared with ISO untreated (17.15 ± 0.6 Vs14.3 ± 0.52 and 13.13 ± 
1.00 ml/min). Also, rats received carnitine or vitamin E alone showed CF significantly increased but less than 
combined (15.2 ± 1.49). However, in the treated groups, the RPP and LVDP indices were significantly better in than 
untreated (p<0.001). The data presented in Table (1) showed that, rats administrated with ISO resulted in a significant 
elevation of serum enzymes (LDH, AST and CK-MB) activity compared with normal rats (p<0.001). Pretreatment with 
vitamin E or carnitine or combined together showed a significant reduction in the activity of these enzymes compared 
with untreated. The reduction doesn't reach to normal value but higher than normal.  The combined effect is more 
significant in effect on CK-MB better than LDH and AST (p<0.01).  
Table (2) showed the marker oxidative stress (MDA and NO) in the cardiac tissue homogenate. The rats 
administrated ISO resulted in a significant elevation in the levels of MDA and NO as compared with control (p<0.001). 
However, pretreatment with vitamin E (100 IU/kg b.w, ip) or carnitine (20 mg/kg b.w, ip) or combined together 
showed a significant reduction. The combined treatment tends to normalize MDA but in NO still higher than normal. 
The activities of cardiac antioxidant enzymes (SOD, GSPxase and GSRase) in the cardiac tissue revealed that, a 
significant elevation in the activity of SOD (p<0.001) whereas a significant reduction in the activities of GSPxase and 
GSRase (p<0.001 and p<0.01) in rats injected with ISO compared to control group. Pretreatment with with vitamin E 
(100 IU/kg b.w, ip) or carnitine (20 mg/kg b.w, ip) or combined together showed a significant decrease in the activity 
of SOD (p<0.001) and a significant elevation (p<0.001) in the activities of GSPxase and GSRase as compared to ISO 
injected group. The combined effect was more significant on GSRase better than other enzymes. But in all treatment 
not reach to normal values. 
Results in table (3) revealed that the levels of IL-6 and TNF-α in tissue extract were significantly elevated 
(p<0.001) in ISO injected rats. Administration of vitamin E with carnitine reduced it (p<0.001) compared with ISO 
untreated. The combined treatment exerted a significant potent action than individual treatment.  
 
 
Table 1: The activities of serum Lactate dehydrogenase (LDH), Aspartae transaminase (AST) and creatine kinase (CK-
MB) inn all studied groups (mean±SD). 
 
Iso+VitE+carnitn Iso+carnitin Iso+Vit E 
 
Iso 
 
Control 
 
Groups 
 
134.8±19 c 
 
63.9±4.5 c 
 
123±11c 
 
199.9±12.3 b 
 
90.4±11 b 
 
165±9b 
 
220±16.5 b 
 
93.4±7.5 b 
 
184±14 b 
 
260±23 a 
 
122.4±8.5 a 
 
273.4±16a 
 
83.4±6.5 
 
45.7±3.5 
 
113±11 
 
LDH (IU/L) 
 
AST (IU/L) 
 
CK-MB (U/L) 
 
Results were expressed as mean ± SD (p<0.05), analysis of variance for multiple comparison by Dennett’s test.  
 a: ISO vs. control. 
 b: ISO vs. individual treatment.  
 c: combined treatment vs. individual treatment. 
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Table 2: Cardiac malondialdehyde (MDA), nitric oxide (NO) levels and the activities of   superoxide dismutase(SOD), 
glutathione peroxidase (GSPaxe) and glutathione reductase (GSRase) in all studied groups (mean± SD) 
 
Iso+VitE+carnitine 
N=9 
Iso+carnitine 
N=8 
Iso+Vit E 
N=9 
ISO 
N=9 
Control 
N=10 
Groups 
31.8±1.9 c 
 
131.8±15 c 
 
154.8±12  
 
380±19  
 
1106±200  
 
41±7.5 b 
 
220±16.5 b 
 
140±13b 
 
370±16.5 b 
 
1110±176b 
53±11 b 
 
201±19.5 b 
 
159±19b 
 
320±43 b 
 
998±98 b 
 
77±13 a 
 
270±33 a 
 
190±33 a 
 
240±43 a 
 
880±76 a 
 
23±2.5 
 
103±12 
 
90.1±8.5 
 
490±63. 
 
1290±193  
 
 
MDA (nmol/g) 
 
NO (ug/g) 
 
SOD(U/g) 
 
GSPXae(U/g) 
 
GSRase 
Results were expressed as mean ± SD (p<0.05), analysis of variance for multiple comparison by Dunnett’s test.  
 a: ISO vs. control. 
 b: ISO vs. individual treatment.  c: combined treatment vs. individual treatment. 
 
Table 3:  cardiac   IL6 and TNF- α levels in different   studied groups (Mean ±SD). 
 
Animal groups  Control  
N=10 
ISO 
N=9 
Iso+Vit E 
N=8 
Iso+carnitin 
N=8 
Iso+VitE+carniti
n 
N=9 
IL-6 (ng/g) 
Mean+ SD 
 
178+ 28 
 
973+66
 a
 
 
810+75
a,b
 
 
604+33
a,c
 
 
401+59
a,,b,c
 
TNF- α (ng/g) 
Mean + SD 
 
10.1+0.9 
 
22+ 3.2
a
 
 
17+2.6
a,b
 
 
15+3.9
a,c 
 
 
13+1.9
 a,,b,c
 
Results were expressed as mean ± SD (p<0.05), analysis of variance for multiple comparison by Dunnett’s test.  
 a: ISO vs. control. 
 b: ISO vs. individual treatment.  
 c: combined treatment vs. individual treatment. 
 
Histopathological Examination  
 
It was found that, control rats showed normal histological architecture manifested by normal coronary artery 
wall thickness, normal size and appearance of cardiac muscles with oval central euchromatic nuclei and normal blood 
capillaries and no necrosis as illustrated in (Figure A). In rats injected with isoproterenol, irregular thickening of 
coronary wall with perivascular mast cell infiltrate and narrow of lumen due to buildup of atheromatous plaque, 
disorganization of cardiac muscle structure with acidophilic dark regions or bands indicating mild necrosis and marked 
congestion of blood capillaries as demonstrated in (Figure B).  Rats treated with carnitine showed highly improvement 
of pathological structure and showed normal thickness of coronary artery with wide lumen without any narrowing, 
preservation of normal structure of cardiac muscles with absence of degenerated dark bands and the nuclei of cells 
looked active and euchromatic (figure C). Treatment with vitamin E showed also normal heart section cardiac muscles 
with no congestion or degeneration with oval central euchromatic nuclei, normal thickness of coronary artery with wide 
lumen without any narrowing (figure D).  Mixture of carnitine and vitamin E revealed a marked improvement in 
histological architecture of the heart tissue and marked congestion blood capillaries and perfective thickness of 
coronary artery with moderate lumen without cholesterol deposition (figure E). 
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Figure 1: Represent myocardium of control rats showing normal architecture of the muscle fibers with abundant wavy 
cytoplasm and small nuclei. 
 
 
Figure 2: Section of myocardium of rats injected with ISO and that most of the myocytes showed increased 
eosinophilia infiltration inside cardiomyocyte. 
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Figure 3: Section of myocardium of rats pretreated with carnitine showed most of myocytes have normal pale granular 
central nuclei. 
 
 
 
Figure 4: Section of myocardium of rats pretreated with vitamin E showed congestion of blood capillaries and absence 
of cross striations. 
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Figure 5: Section of myocardium section of myocardium of rats pretreated with carnitine and vitamin E showed no 
apparent changes in cardiac myocyte staining intensity.  
 
Discussion 
 
The patho-physiological and morphologic alterations in the heart of this non-coronary myocardial necrotic rat 
model are similar to those taking place in human myocardial infarction [Spagnoli etal.,1982]. By studying the 
biochemical alterations that take place in an animal model, it is possible to gain more insight into the mechanisms 
leading to the altered process in human MI [Weitz etal.,1991]. The present study has clearly demonstrated that, 
carnitine and vitamin E possess antioxidant activity which could prevent the occurrence of heart related diseases via 
free radical scavenger. 
It has been suggested that the cardio protective effect of carnitine and vitamin E is due to anti-inflammatory 
and antioxidant activities on coronary endothelial function and vasoreactivity [Yuncu etal.,2015]. Also, it has been 
shown that Vitamin E improved endothelial function with CHD [Mahmoud etal.,2015]. In current study carnitine and 
vitamin E increased the CF in rats injected with ISO compared with untreated. This is may be due to their vasodilator 
activity on blood vessels.  
Serum LDH, AST and CK-MB activities are sensitive markers to evaluate the severity of myocardial 
infarction [Whellen,2005]. In the present study, the increased activities of these enzymes after administration of ISO in 
rats as a marker for the occurrence of myocardial dysfunction was in accordance with results as mentioned [Dhalla 
etal.,1996]. Pretreatment with carnitine and vitamin E reduced the activities of these enzymes compared with untreated. 
This is an indication of the protective effect of the combined action of carnitine and vitamin E in reversing cardiac 
damage and recovery of myocyte. Previous study indicated that, L-carnitine administration have a cardio protective 
role in cardio-myopathy, prevention of myocardial infarction [Lango etal.,2001]. Arsenian et al [1996] demonstrated a 
decrease in mortality and incidence of circulatory failure in patients with acute myocardial infarction who were 
administered of L-carnitine with glucose, insulin, potassium and magnesium. 
The antioxidant enzymes play an important role in free radical scavenger and protection against oxidative 
stress. Superoxide dismutase convert peroxyradical to superoxide which converted by catalase to water. In the current 
study, ISO injected to rats resulted in enhancement in initiation and propagation of lipid peroxidion in myocyte that 
decrease the efficacy of myocyte and lower the blood supply to the heart [Yusuf etal.,2000]. ISO induced myocardial 
infarction by stimulation of SOD activity, and a significant reduction in GSPaxe and GSrase compared with control. 
Carnitine and vitamin E treatment reverse the action of ISO by reduction of SOD and elevation of GSPaxe and GSrase. 
This result may be due to upregulation effect of carnitine and vitamin E on GSPaxe and GSrase and downregulation 
effect on SOD. Previous study indicated that, the incidence of infarction decreased 5 % among intake of vitamin E 
compared with the non-recipients. However, the observed effect did not reach statistical significance that is in 
accordance with the present study. 
In the current study, rats injected with ISO caused a significant elevation of inflammatory markers as (IL-6 
and TNF-α) that cause damage of liver tissue.  Treatment with combination of vitamin E and carnitine caused a 
reduction in these mediators and recovery of cardiocyte as indicated by a decrease in CK-MB and LDH activities. The 
histopathological examination support the biochemical study as indicated by improvement of myocyte fibers in 
treatment with vitamin E and carnitine and disappearance of necrosis. This study explained that administrations of ISO 
induced production of cardiac lipid peroxidation and inflammatory mediators that caused necrosis and infarction. 
However, pretreatments of carnitine and vitamin E act as radical scavenger and suppression release of these mediators 
to reverse this action. This is in accordance to previous study reported, oxidative stress has been implicated in 
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cardiovascular disease. Many of the deleterious cellular myocardium may be attributed to ROS and oxidative stress 
[Mann etal.,2004]. Experimental studies with antioxidants support the hypothesis that oxidative stress is pathogenic in 
myocardial remodeling and failure. The histopathological examinations support the biochemical analysis by improving 
the caridocyte with reduction in infiltration of monocyte in rats supplemented with both carnitine and vitamin E.  
 
Conclusion 
 
Combination of carnitine with vitamin E pretreatment normalized the levels of malondialdehyde and 
antioxidant enzymes of cardiac tissue in rats injected with ISO. Further studies are needed to determine signal mediated 
by which vitamin E and carnitine protective effect against MI. 
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